[1]JournalofMedicinalChemistry,1998,vol.41,p.5219-5246
[2]Patent:CN109970681,2019,A.Locationinpatent:Paragraph0043;0053;0054
[3]AsianJournalofChemistry,2013,vol.25,p.9345-9350
[4]Patent:US2008/200684,2008,A1.Locationinpatent:Page/Pagecolumn4
[5]Patent:US2010/197732,2010,A1.Locationinpatent:Page/Pagecolumn13-14
[6]Patent:WO2004/103983,2004,A1.Locationinpatent:Page7;8
[7]Chimia,2006,vol.60,p.593-597
[8]Patent:EP2019097,2009,A1.Locationinpatent:Page/Pagecolumn8
[9]Patent:WO2004/101540,2004,A2.Locationinpatent:Page/Pagecolumn13-14
[10]Patent:WO2004/101540,2004,A2.Locationinpatent:Page/Pagecolumn15-16
[11]Patent:EP2177221,2010,A1.Locationinpatent:Page/Pagecolumn15
[1]Chimia,2006,vol.60,p.593-597
[1]Chimia,2006,vol.60,p.593-597
[1]Chimia,2006,vol.60,p.593-597
[1]Chimia,2006,vol.60,p.593-597
[2]JournalofMedicinalChemistry,1998,vol.41,p.5219-5246
[3]AsianJournalofChemistry,2013,vol.25,p.9345-9350
[4]Patent:CN109970681,2019,A
[5]Patent:CN109970681,2019,A
Title: Toxicological evaluation of acyl glucuronides utilizing half-lives, peptide adducts, and immunostimulation assays.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20151225
Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology 20150518
Title: Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201
Title: A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131101
Title: The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members.
Journal: Basic & clinical pharmacology & toxicology 20130401
Title: In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.
Journal: Drug development and industrial pharmacy 20121101
Title: Validated stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of repaglinide in tablets.
Journal: Journal of fluorescence 20121101
Title: Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study.
Journal: Diabetes & vascular disease research 20121001
Title: NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes.
Journal: British journal of clinical pharmacology 20120901
Title: Analysis of repaglinide enantiomers in pharmaceutical formulations by capillary electrophoresis using 2,6-di-o-methyl-β-cyclodextrin as a chiral selector.
Journal: Journal of chromatographic science 20120901
Title: Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120901
Title: Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120801
Title: A comprehensive assessment of repaglinide metabolic pathways: impact of choice of in vitro system and relative enzyme contribution to in vitro clearance.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120701
Title: Synthesis, in vitro and in silico screening of ethyl 2-(6-substituted benzo[d]thiazol-2-ylamino)-2-oxoacetates as protein-tyrosine phosphatase 1B inhibitors.
Journal: European journal of medicinal chemistry 20120701
Title: Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Journal: Journal of medicinal chemistry 20120524
Title: Association of muscarinic M₃ receptors and Kir6.1 with caveolae in human detrusor muscle.
Journal: European journal of pharmacology 20120515
Title: Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514
Title: Adulteration of herbal antidiabetic products with undeclared pharmaceuticals: a case series in Hong Kong.
Journal: British journal of clinical pharmacology 20120501
Title: Influence of atorvastatin on the pharmacodynamic and pharmacokinetic activity of repaglinide in rats and rabbits.
Journal: Molecular and cellular biochemistry 20120501
Title: Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20120501
Title: KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetic patients.
Journal: Clinical and experimental pharmacology & physiology 20120501
Title: Gemfibrozil is a strong inactivator of CYP2C8 in very small multiple doses.
Journal: Clinical pharmacology and therapeutics 20120501
Title: [Hypoglycemia - frequency, causes, induced costs].
Journal: Deutsche medizinische Wochenschrift (1946) 20120501
Title: The pharmacokinetics and hepatic disposition of repaglinide in pigs: mechanistic modeling of metabolism and transport.
Journal: Molecular pharmaceutics 20120402
Title: Simultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic model.
Journal: The Journal of pharmacology and experimental therapeutics 20120401
Title: Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic K(ATP) channel.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20120301
Title: Role of the amino-terminal transmembrane domain of sulfonylurea receptor SUR2B for coupling to K(IR)6.2, ligand binding, and oligomerization.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20120301
Title: In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions.
Journal: Pharmaceutical research 20120201
Title: Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
Journal: Diabetes, obesity & metabolism 20120201
Title: Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.
Journal: Journal of pharmacokinetics and pharmacodynamics 20120201
Title: Association of a SLC30A8 genetic variant with monotherapy of repaglinide and rosiglitazone effect in newly diagnosed type 2 diabetes patients in China.
Journal: Biomedical and environmental sciences : BES 20120201
Title: Repaglinide: a review of its use in type 2 diabetes mellitus.
Journal: Drugs 20120122
Title: Design and optimization of a stomach-specific drug delivery system of repaglinide: application of simplex lattice design.
Journal: Pharmaceutical development and technology 20120101
Title: From evidence assessments to coverage decisions?: the case example of glinides in Germany.
Journal: Health policy (Amsterdam, Netherlands) 20120101
Title: Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.
Journal: Journal of drug delivery 20120101
Title: Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.
Journal: Journal of clinical pharmacology 20120101
Title: Platelet hyperaggregability in high-fat fed rats: a role for intraplatelet reactive-oxygen species production.
Journal: Cardiovascular diabetology 20120101
Title: Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress.
Journal: Experimental diabetes research 20120101
Title: In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
Journal: International journal of nanomedicine 20120101
Title: Editorial preface to the first issue of 2012.
Journal: Journal of cardiovascular disease research 20120101
Title: Athero-protective actions of two oral antidiabetic drugs: Suppression of inflammation and oxidative stress.
Journal: Journal of cardiovascular disease research 20120101
Title: Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits.
Journal: Journal of cardiovascular disease research 20120101
Title: Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome.
Journal: BMC nephrology 20120101
Title: Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes.
Journal: Die Pharmazie 20120101
Title: The Influence of MDR1 G2677T/a genetic polymorphisms on the pharmacokinetics of repaglinide in healthy Chinese volunteers.
Journal: Pharmacology 20120101
Title: Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion.
Journal: Chemical & pharmaceutical bulletin 20120101
Title: Oxidative/nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide.
Journal: Experimental diabetes research 20120101
Title: Performance scores in general practice: a comparison between the clinical versus medication-based approach to identify target populations.
Journal: PloS one 20120101
Title: Uncovering undetected hypoglycemic events.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20120101
Title: [Prevalence of diabetes mellitus in geriatric patients in nursing homes of Cádiz. Diagerca study].
Journal: Revista espanola de geriatria y gerontologia 20120101
Title: Efficacy of various antidiabetic agents as add-on treatments to metformin in type 2 diabetes mellitus: systematic review and meta-analysis.
Journal: ISRN endocrinology 20120101
Title: Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20120101
Title: Antidiabetic drugs and kidney disease--recommendations of the Swiss Society for Endocrinology and Diabetology.
Journal: Swiss medical weekly 20120101
Title: Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy.
Journal: Expert opinion on pharmacotherapy 20111201
Title: Noninsulin treatment of type 2 diabetes mellitus in geriatric patients: a review.
Journal: Clinical therapeutics 20111201
Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Journal: PLoS computational biology 20111201
Title: Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
Journal: Diabetes research and clinical practice 20111101
Title: The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial.
Journal: International journal of clinical practice 20111101
Title: Hypoglycemia revisited in the acute care setting.
Journal: Yonsei medical journal 20111101
Title: Transfer of repaglinide in the dually perfused human placenta and the role of organic anion transporting polypeptides (OATPs).
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111009
Title: Kinetic characterization of rat hepatic uptake of 16 actively transported drugs.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20111001
Title: Dose-dependent interaction between gemfibrozil and repaglinide in humans: strong inhibition of CYP2C8 with subtherapeutic gemfibrozil doses.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20111001
Title: Effect of nicotinamide mononucleotide on insulin secretion and gene expressions of PDX-1 and FoxO1 in RIN-m5f cells.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20111001
Title: The Effects of Glyburide on Apoptosis and Endoplasmic Reticulum Stress in INS-1 Cells in a Glucolipotoxic Condition.
Journal: Diabetes & metabolism journal 20111001
Title: Glitazone-like action of glimepiride and glibenclamide in primary human adipocytes.
Journal: Diabetes, obesity & metabolism 20110901
Title: Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20110901
Title: Evaluation of CYP2C8 inhibition in vitro: utility of montelukast as a selective CYP2C8 probe substrate.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110901
Title: The pregnane X receptor agonist St John's Wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.
Journal: Clinical pharmacokinetics 20110901
Title: Enhanced glycemic control with combination therapy for type 2 diabetes in primary care.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders 20110901
Title: Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study.
Journal: European heart journal 20110801
Title: NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus.
Journal: Clinical and experimental pharmacology & physiology 20110801
Title: Lipid nanocarriers (GeluPearl) containing amphiphilic lipid Gelucire 50/13 as a novel stabilizer: fabrication, characterization and evaluation for oral drug delivery.
Journal: Nanotechnology 20110708
Title: Expression of sulfonylurea receptors in rat taste buds.
Journal: Acta histochemica 20110701
Title: Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers.
Journal: European journal of clinical pharmacology 20110701
Title: Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Journal: Journal of pharmaceutical sciences 20110601
Title: In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.
Journal: Journal of pharmaceutical sciences 20110601
Title: Hydrogels based on interpenetrating network of chitosan and polyvinyl pyrrolidone for pH-sensitive delivery of repaglinide.
Journal: Current drug discovery technologies 20110601
Title: Assessing the association of pioglitazone use and bladder cancer through drug adverse event reporting.
Journal: Diabetes care 20110601
Title: Exenatide improves weight loss insulin sensitivity and β-cell function following administration to a type 2 diabetic HIV patient on antiretroviral therapy.
Journal: Annales d'endocrinologie 20110601
Title: Primary language, income and the intensification of anti-glycemic medications in managed care: the (TRIAD) study.
Journal: Journal of general internal medicine 20110501
Title: A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism 20110501
Title: Effect of the CYP2C8 genotype on the pharmacokinetics and pharmacodynamics of repaglinide.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20110501
Title: [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
Journal: Deutsche medizinische Wochenschrift (1946) 20110501
Title: Simultaneous identification and validated quantification of 11 oral hypoglycaemic drugs in plasma by electrospray ionisation liquid chromatography-mass spectrometry.
Journal: Analytical and bioanalytical chemistry 20110401
Title: Mechanism-based inactivation of CYP2C8 by gemfibrozil occurs rapidly in humans.
Journal: Clinical pharmacology and therapeutics 20110401
Title: Diabetes treatment and cardiovascular safety.
Journal: Diabetes care 20110401
Title: Cohort study of pioglitazone and cancer incidence in patients with diabetes.
Journal: Diabetes care 20110401
Title: A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.
Journal: Journal of medicinal chemistry 20110324
Title: Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.
Journal: European journal of endocrinology 20110301
Title: Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes.
Journal: Clinical pharmacology and therapeutics 20110301
Title: Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201
Title: Validated spectrophotometric methods for determination of some oral hypoglycemic drugs.
Journal: Drug discoveries & therapeutics 20110201
Title: Aqueous Extract from Hibiscus sabdariffa Linnaeus Ameliorate Diabetic Nephropathy via Regulating Oxidative Status and Akt/Bad/14-3-3γ in an Experimental Animal Model.
Journal: Evidence-based complementary and alternative medicine : eCAM 20110101
Title: Small molecule inhibitors of the human papillomavirus E1-E2 interaction.
Journal: Current topics in microbiology and immunology 20110101
Title: Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules.
Journal: Journal of biomedicine & biotechnology 20110101
Title: Effect of repaglinide versus glyburide on postprandial glucose and insulin values in elderly patients with type 2 diabetes.
Journal: Diabetes technology & therapeutics 20110101
Title: Understanding diabetes in patients with HIV/AIDS.
Journal: Diabetology & metabolic syndrome 20110101
Title: Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006.
Journal: Cardiovascular diabetology 20110101
Title: Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
Journal: Current drug metabolism 20110101
Title: Effect of repaglinide and gliclazide on glycaemic control, early-phase insulin secretion and lipid profiles in.
Journal: Chinese medical journal 20110101
Title: 2-Deoxy-D-glucose reverses the Indian red scorpion venom-induced cardiopulmonary abnormalities in anesthetized rats.
Journal: Indian journal of experimental biology 20110101
Title: Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress.
Journal: Biologics : targets & therapy 20110101
Title: Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20110101
Title: Hypersensitivity to repaglinide.
Journal: Journal of investigational allergology & clinical immunology 20110101
Title: Multiple thromboembolism with multiple causes in a 69-year-old woman: a case report.
Journal: Journal of medical case reports 20110101
Title: Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report.
Journal: Journal of medical case reports 20110101
Title: Diabetes and Ramadan: an update on use of glycemic therapies during fasting.
Journal: Annals of Saudi medicine 20110101
Title: Extensive Spinal Cord Injury following Staphylococcus aureus Septicemia and Meningitis.
Journal: Case reports in neurology 20110101
Title: New onset diabetes after transplantation (NODAT): an overview.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20110101
Title: Small molecule inhibitors of human papillomavirus protein - protein interactions.
Journal: The open virology journal 20110101
Title: Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations.
Journal: Journal of nutrition and metabolism 20110101
Title: Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Journal: PloS one 20110101
Title: A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients.
Journal: Health and quality of life outcomes 20110101
Title: Medicinal chemistry of novel anti-diabetic drugs.
Journal: The open medicinal chemistry journal 20110101
Title: South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome.
Journal: Indian journal of endocrinology and metabolism 20110101
Title: Ramadan and diabetes: As-Saum (The fasting).
Journal: Indian journal of endocrinology and metabolism 20110101
Title: [Genetic polymorphisms of SLCO1B1 for drug pharmacokinetics and its clinical implications].
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110101
Title: Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.
Journal: Open medicine : a peer-reviewed, independent, open-access journal 20110101
Title: Novel anti-inflammatory effects of repaglinide in rodent models of inflammation.
Journal: Pharmacology 20110101
Title: Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.
Journal: Particle and fibre toxicology 20110101
Title: Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone.
Journal: Diabetology & metabolic syndrome 20110101
Title: Management of diabetes across the course of disease: minimizing obesity-associated complications.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20110101
Title: In silico identification of structure requirement for novel thiazole and oxazole derivatives as potent fructose 1,6-bisphosphatase inhibitors.
Journal: International journal of molecular sciences 20110101
Title: Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report.
Journal: Case reports in medicine 20110101
Title: Multiple myeloma and diabetes.
Journal: ISRN endocrinology 20110101
Title: Separation and quantification of eight antidiabetic drugs on a high-performance liquid chromatography: its application to human plasma assay.
Journal: ISRN pharmaceutics 20110101
Title: Formulation and evaluation of transdermal patch of repaglinide.
Journal: ISRN pharmaceutics 20110101
Title: Carbamazepine-induced acute generalized exanthematous pustulosis: a case report.
Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20110101
Title: Angelica archengelica extract induced perturbation of rat skin and tight junctional protein (ZO-1) of HaCaT cells.
Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101
Title: Updated review: improved glycemic control with repaglinide-metformin in fixed combination for patients with type 2 diabetes.
Journal: Clinical medicine insights. Endocrinology and diabetes 20110101
Title: Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study.
Journal: Diabetes care 20101201
Title: Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Journal: European journal of clinical pharmacology 20101201
Title: Smoking and risk for diabetes incidence and mortality in Korean men and women.
Journal: Diabetes care 20101201
Title: Acute pancreatitis in association with type 2 diabetes and antidiabetic drugs: a population-based cohort study.
Journal: Diabetes care 20101201
Title: Electrochemical characterization of repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101201
Title: Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement.
Journal: Diabetes care 20101201
Title: Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society.
Journal: Diabetes care 20101201
Title: Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism.
Journal: British journal of clinical pharmacology 20101201
Title: Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders 20101201
Title: Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.
Journal: Diabetes care 20101101
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: SLCO1B1 polymorphism and oral antidiabetic drugs.
Journal: Basic & clinical pharmacology & toxicology 20101001
Title: [Electrocardiographic score: application in exercise test for the assessment of ischemic preconditioning].
Journal: Arquivos brasileiros de cardiologia 20101001
Title: Organic solvent-free approach to single step fabrication of Eudragit nanoparticles using Labrasol.
Journal: Die Pharmazie 20101001
Title: Sitagliptin-induced hemolysis.
Journal: Indian journal of pharmacology 20101001
Title: [Sulfonylureas dosage: from therapeutic monitoring to differential diagnosis of hyperinsulinism].
Journal: Revue medicale de Liege 20100901
Title: In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.
Journal: International journal of pharmaceutics 20100830
Title: The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis.
Journal: Diabetes care 20100801
Title: Recommendations for management of diabetes during Ramadan: update 2010.
Journal: Diabetes care 20100801
Title: Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.
Journal: Therapeutic delivery 20100701
Title: Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil.
Journal: Acta diabetologica 20100601
Title: Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
Journal: International journal of clinical practice 20100601
Title: Neuropathy, retinopathy, and glucose-lowering treatments.
Journal: Diabetes care 20100601
Title: IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.
Journal: Acta pharmacologica Sinica 20100601
Title: Effect of the bile acid sequestrant colesevelam on the pharmacokinetics of pioglitazone, repaglinide, estrogen estradiol, norethindrone, levothyroxine, and glyburide.
Journal: Journal of clinical pharmacology 20100501
Title: The nasty surprise of a complex drug-drug interaction.
Journal: Drug discovery today 20100501
Title: Effects of short-term therapy with different insulin secretagogues on glucose metabolism, lipid parameters and oxidative stress in newly diagnosed Type 2 Diabetes Mellitus.
Journal: Diabetes research and clinical practice 20100401
Title: Coping with changes in the Defined Daily Dose in a longitudinal drug consumption database.
Journal: Pharmacy world & science : PWS 20100401
Title: Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
Journal: The Annals of pharmacotherapy 20100401
Title: Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.
Journal: Annals of the rheumatic diseases 20100401
Title: A variation in NOS1AP gene is associated with repaglinide efficacy on insulin resistance in type 2 diabetes of Chinese.
Journal: Acta pharmacologica Sinica 20100401
Title: KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes.
Journal: Clinical pharmacology and therapeutics 20100301
Title: Post-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin.
Journal: Journal of Korean medical science 20100301
Title: Comparison of insulin sensitivity, glucose sensitivity, and first phase insulin secretion in patients treated with repaglinide or gliclazide.
Journal: Archives of pharmacal research 20100301
Title: Opening of ATP-sensitive potassium channel by insulin in the brain-induced insulin secretion in Wistar rats.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20100201
Title: Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers.
Journal: Journal of clinical pharmacology 20100201
Title: Diabetes under control: Understanding oral antidiabetic agents.
Journal: The American journal of nursing 20100201
Title: Population pharmacokinetic modelling of repaglinide in healthy volunteers by using Non-Parametric Adaptive Grid Algorithm.
Journal: Journal of clinical pharmacy and therapeutics 20100201
Title: Bioavailability and biological activity of liquisolid compact formula of repaglinide and its effect on glucose tolerance in rabbits.
Journal: Bioscience trends 20100201
Title: Aspects of insulin treatment.
Journal: Diabetes care 20100101
Title: Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method.
Journal: Current drug delivery 20100101
Title: Effect of meglitinides on postprandial ghrelin secretion pattern in type 2 diabetes mellitus.
Journal: Diabetes technology & therapeutics 20100101
Title: Anti-hyperglycemic and anti-hyperlipidemic effects of guava leaf extract.
Journal: Nutrition & metabolism 20100101
Title: Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.
Journal: Mediators of inflammation 20100101
Title: Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.
Journal: BMJ (Clinical research ed.) 20100101
Title: Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
Journal: Vascular health and risk management 20100101
Title: Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3.
Journal: Current chemical genomics 20100101
Title: Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial.
Journal: BMJ (Clinical research ed.) 20100101
Title: CYP3A4 genetic polymorphism influences repaglinide's pharmacokinetics.
Journal: Pharmacology 20100101
Title: Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society.
Journal: Diabetology & metabolic syndrome 20100101
Title: Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects.
Journal: PloS one 20100101
Title: The well-being and treatment satisfaction of diabetic patients in primary care.
Journal: Health and quality of life outcomes 20100101
Title: The tsim tsoum approaches for prevention of cardiovascular disease.
Journal: Cardiology research and practice 20100101
Title: Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study.
Journal: Health and quality of life outcomes 20100101
Title: Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors.
Journal: Cardiovascular diabetology 20100101
Title: Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide.
Journal: Indian journal of pharmaceutical sciences 20100101
Title: Characteristics of coronary artery disease in symptomatic type 2 diabetic patients: evaluation with CT angiography.
Journal: Cardiovascular diabetology 20100101
Title: Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus.
Journal: Nutrition & metabolism 20100101
Title: Carbamazepine-loaded porous microspheres for short-term sustained drug delivery.
Journal: Journal of young pharmacists : JYP 20100101
Title: In vitro Evaluation of Novel Sustained Release Microspheres of Glipizide Prepared by the Emulsion Solvent Diffusion-Evaporation Method.
Journal: Journal of young pharmacists : JYP 20100101
Title: Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20100101
Title: Impact of rosiglitazone meta-analysis on use of glucose-lowering medications.
Journal: Open medicine : a peer-reviewed, independent, open-access journal 20100101
Title: Design and optimization of floating drug delivery system of acyclovir.
Journal: Indian journal of pharmaceutical sciences 20100101
Title: Nateglinide versus repaglinide for type 2 diabetes mellitus in China.
Journal: Acta diabetologica 20091201
Title: Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
Journal: Diabetes care 20091201
Title: CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20091201
Title: Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement.
Journal: International journal of clinical practice 20091101
Title: Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines.
Journal: Diabetes care 20091101
Title: Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes.
Journal: Diabetes care 20091101
Title: Metabolomics applied to diabetes research: moving from information to knowledge.
Journal: Diabetes 20091101
Title: Twice-daily and three-times-daily dosing of a repaglinide/metformin fixed-dose combination tablet provide similar glycaemic control.
Journal: Diabetes, obesity & metabolism 20091001
Title: Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.
Journal: Diabetes 20091001
Title: Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.
Journal: Diabetes care 20091001
Title: Accuracy of Veterans Affairs databases for diagnoses of chronic diseases.
Journal: Preventing chronic disease 20091001
Title: Impact of OATP transporters on pharmacokinetics.
Journal: British journal of pharmacology 20091001
Title: Twice-daily dosing of a repaglinide/metformin fixed-dose combination tablet provides glycaemic control comparable to rosiglitazone/metformin tablet.
Journal: Diabetes, obesity & metabolism 20090901
Title: The role of transporters in the pharmacokinetics of orally administered drugs.
Journal: Pharmaceutical research 20090901
Title: Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies.
Journal: Pharmacogenomics 20090901
Title: Global variation in CYP2C8-CYP2C9 functional haplotypes.
Journal: The pharmacogenomics journal 20090801
Title: Thiazolidinediones and cardiovascular risk - a question of balance.
Journal: Current cardiology reviews 20090801
Title: Change in glucometer settings as a cause of sudden deterioration of glycemic control in type 2 diabetes.
Journal: Diabetes technology & therapeutics 20090701
Title: Successful treatment of repaglinide-induced hypoglycemia with octreotide.
Journal: The American journal of emergency medicine 20090701
Title: Metformin/Repaglinide (PrandiMet) for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics 20090601
Title: Modulation of nitrosative/oxidative stress in the lung of hyperglycemic rabbits by two antidiabetics, pioglitazone and repaglinide.
Journal: Experimental lung research 20090601
Title: Determination of antihyperglycemic drugs in nanomolar concentration levels by micellar electrokinetic chromatography with non-ionic surfactant.
Journal: Journal of chromatography. A 20090515
Title: Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.
Journal: Clinics (Sao Paulo, Brazil) 20090501
Title: Development of the renal glucose reabsorption inhibitors: a new mechanism for the pharmacotherapy of diabetes mellitus type 2.
Journal: Journal of medicinal chemistry 20090409
Title: Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers.
Journal: Journal of proteome research 20090401
Title: Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
Journal: The Journal of biological chemistry 20090313
Title: Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
Journal: Acta diabetologica 20090301
Title: Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
Journal: Acta diabetologica 20090301
Title: Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.
Journal: Current medical research and opinion 20090301
Title: Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
Journal: Journal of diabetes 20090301
Title: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Journal: Diabetes care 20090101
Title: Standards of medical care in diabetes--2009.
Journal: Diabetes care 20090101
Title: The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese Type 2 diabetic patients.
Journal: Journal of endocrinological investigation 20090101
Title: Postprandial hyperglycemia as an etiological factor in vascular failure.
Journal: Cardiovascular diabetology 20090101
Title: Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
Journal: Drug safety 20090101
Title: DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.
Journal: BMC endocrine disorders 20090101
Title: Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose.
Journal: Nutrition journal 20090101
Title: Co-solvent solubilization of some poorly-soluble antidiabetic drugs.
Journal: Pharmaceutical development and technology 20090101
Title: Acute heart failure in a patient with metabolic syndrome and diabetes mellitus: clinical evidence for direct positive influence of antidiabetic therapy on left ventricular function.
Journal: Congestive heart failure (Greenwich, Conn.) 20090101
Title: A cardiologic approach to non-insulin antidiabetic pharmacotherapy in patients with heart disease.
Journal: Cardiovascular diabetology 20090101
Title: Evaluation of the repaglinide efficiency in comparison to the glimepiride in the type 2 diabetes patients poorly regulated by the metmorfine administration.
Journal: Bratislavske lekarske listy 20090101
Title: Drugs associated with more suicidal ideations are also associated with more suicide attempts.
Journal: PloS one 20090101
Title: Diabetic nephropathy.
Journal: Diabetology & metabolic syndrome 20090101
Title: Post-transplant diabetes mellitus.
Journal: Diabetology & metabolic syndrome 20090101
Title: Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial.
Journal: BMJ (Clinical research ed.) 20090101
Title: Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.
Journal: BMJ (Clinical research ed.) 20090101
Title: Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
Journal: Experimental diabetes research 20090101
Title: Effect of Ramadan fasting on anthropometric parameters and food consumption in 276 type 2 diabetic obese women.
Journal: International journal of diabetes in developing countries 20090101
Title: Repaglinide induced acute hepototoxicity.
Journal: JNMA; journal of the Nepal Medical Association 20090101
Title: Role of potassium channels in stretch-promoted atrial natriuretic factor secretion.
Journal: Journal of the American Society of Hypertension : JASH 20090101
Title: pH-Sensitive Mebeverine Microspheres for Colon Delivery.
Journal: Indian journal of pharmaceutical sciences 20090101
Title: Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam - a clinical perspective.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20090101
Title: Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20090101
Title: Fixed combination of repaglinide and metformin in the management of type 2 diabetes.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy 20090101
Title: Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column.
Journal: Journal of chromatography. A 20081226
Title: Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Journal: Diabetes, obesity & metabolism 20081201
Title: The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range.
Journal: British journal of clinical pharmacology 20081201
Title: Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes.
Journal: Vascular health and risk management 20081201
Title: Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes.
Journal: Vascular health and risk management 20081201
Title: Metformin, sulfonylureas, or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia: a nested case-control analysis.
Journal: Diabetes care 20081101
Title: Effects of the SLCO1B1*1B haplotype on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
Journal: Pharmacogenetics and genomics 20081101
Title: Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Journal: Journal of medicinal chemistry 20081009
Title: Weight change in diabetes and glycemic and blood pressure control.
Journal: Diabetes care 20081001
Title: Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin.
Journal: Chemical biology & drug design 20081001
Title: International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20081001
Title: Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism.
Journal: Clinical pharmacology and therapeutics 20081001
Title: The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.
Journal: Clinical pharmacology and therapeutics 20080901
Title: Application of software design principles and debugging methods to an analgesia prescription reduces risk of severe injury from medical use of opioids.
Journal: Clinical pharmacology and therapeutics 20080901
Title: Glycemic control in diabetes: a tale of three studies.
Journal: Diabetes care 20080901
Title: Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism.
Journal: The pharmacogenomics journal 20080801
Title: Synthesis of hydantoin analogues of (2S,3R,4S)-4-hydroxyisoleucine with insulinotropic properties.
Journal: Bioorganic & medicinal chemistry letters 20080801
Title: Approaches to treatment of type 2 diabetes.
Journal: Diabetes care 20080801
Title: Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients.
Journal: Acta pharmacologica Sinica 20080801
Title: Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence.
Journal: Diabetes 20080701
Title: Drugs for type 2 diabetes.
Journal: Treatment guidelines from the Medical Letter 20080701
Title: Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Journal: Diabetes 20080601
Title: Interaction of Aqueous Extract of Pleurotus pulmonarius (Fr.) Quel-Champ. with Glyburide in Alloxan Induced Diabetic Mice.
Journal: Evidence-based complementary and alternative medicine : eCAM 20080601
Title: Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical.
Journal: The AAPS journal 20080601
Title: Multiple inhibition mechanisms and prediction of drug-drug interactions: status of metabolism and transporter models as exemplified by gemfibrozil-drug interactions.
Journal: Pharmaceutical research 20080501
Title: Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes.
Journal: European journal of endocrinology 20080501
Title: Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
Journal: Pharmacotherapy 20080501
Title: Development and validation of a liquid chromatography/tandem mass spectrometry assay for the simultaneous determination of nateglinide, cilostazol and its active metabolite 3,4-dehydro-cilostazol in Wistar rat plasma and its application to pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080401
Title: [Clinical evaluation of efficacy and safety of nateglinide in the treatment of type 2 diabetes].
Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20080401
Title: Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs.
Journal: Acta diabetologica 20080301
Title: Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
Journal: Journal of clinical pharmacology 20080301
Title: Hypoglycaemia in Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20080301
Title: Spermicidal activity of sulfonylureas and meglitinide analogues: role of intrasperm Ca2+ elevation.
Journal: The Journal of pharmacy and pharmacology 20080301
Title: Achieving glycosylated hemoglobin targets using the combination of repaglinide and metformin in type 2 diabetes: a reanalysis of earlier data in terms of current targets.
Journal: Clinical therapeutics 20080301
Title: Postprandial hyperglycemia: are all sulfonylureas created equal?
Journal: The American journal of cardiology 20080215
Title: Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.
Journal: European journal of clinical pharmacology 20080201
Title: Ameliorating effects of sulfonylurea drugs on insulin resistance in Otsuka long-evans Tokushima Fatty rats.
Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20080201
Title: Safety and efficacy of repaglinide in combination with metformin and bedtime NPH insulin as an insulin treatment regimen in type 2 diabetes.
Journal: Diabetes research and clinical practice 20080101
Title: Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Journal: European journal of endocrinology 20080101
Title: Electrochemical determination of the antidiabetic drug repaglinide.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080101
Title: Radioiodinated naphthylalanine derivatives targeting pancreatic beta cells in normal and nonobese diabetic mice.
Journal: Experimental diabetes research 20080101
Title: The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada.
Journal: BMC health services research 20080101
Title: A comparative study of first-derivative spectrophotometry and column high-performance liquid chromatography applied to the determination of repaglinide in tablets and for dissolution testing.
Journal: Journal of AOAC International 20080101
Title: Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
Journal: Clinical drug investigation 20080101
Title: Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
Journal: PloS one 20080101
Title: Diabetes: glycaemic control in type 2.
Journal: BMJ clinical evidence 20080101
Title: Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice.
Journal: International journal of clinical practice 20071201
Title: A review of nateglinide in the management of patients with type 2 diabetes.
Journal: Vascular health and risk management 20071201
Title: Optimizing combination treatment in the management of type 2 diabetes.
Journal: Vascular health and risk management 20071001
Title: A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.
Journal: Vascular health and risk management 20071001
Title: Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
Journal: Annals of internal medicine 20070918
Title: Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070901
Title: Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Journal: The Journal of pharmacology and experimental therapeutics 20070801
Title: Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.
Journal: The Journal of clinical investigation 20070801
Title: Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes.
Journal: Current medical research and opinion 20070801
Title: Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process.
Journal: AAPS PharmSciTech 20070720
Title: A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20070701
Title: Improvement of insulin sensitivity and beta-cell function by nateglinide and repaglinide in type 2 diabetic patients - a randomized controlled double-blind and double-dummy multicentre clinical trial.
Journal: Diabetes, obesity & metabolism 20070701
Title: Development of a RP-HPLC method for screening potentially counterfeit anti-diabetic drugs.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070615
Title: Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
Journal: International journal of clinical practice. Supplement 20070601
Title: Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
Journal: Diabetes, obesity & metabolism 20070501
Title: Meglitinide analogues for type 2 diabetes mellitus.
Journal: The Cochrane database of systematic reviews 20070418
Title: Method development and validation of repaglinide in human plasma by HPLC and its application in pharmacokinetic studies.
Journal: Journal of pharmaceutical and biomedical analysis 20070411
Title: New oral agents for type 2 diabetes.
Journal: Clinical medicine (London, England) 20070401
Title: Porous carrier based floating granular delivery system of repaglinide.
Journal: Drug development and industrial pharmacy 20070401
Title: [Chronic kidney disease and antidiabetic treatment].
Journal: Revue medicale suisse 20070307
Title: A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
Journal: Diabetes research and clinical practice 20070201
Title: Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
Journal: Vascular pharmacology 20070201
Title: Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris.
Journal: Coronary artery disease 20070201
Title: Twelve weeks' treatment with diazoxide without insulin supplementation in Type 2 diabetes is feasible but does not improve insulin secretion.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20070201
Title: Use of repaglinide on a pregnant woman during embryogenesis.
Journal: Diabetes, obesity & metabolism 20070101
Title: Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
Journal: Clinical pharmacokinetics 20070101
Title: Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analogues.
Journal: Health and quality of life outcomes 20070101
Title: Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes.
Journal: Cardiovascular diabetology 20070101
Title: Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101
Title: Rapid identification of P-glycoprotein substrates and inhibitors.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20061201
Title: Preprandial repaglinide decreases exogenous insulin requirements and HbA1c levels in type 2 diabetic patients taking intensive insulin treatment.
Journal: Acta diabetologica 20061201
Title: Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.
Journal: British journal of clinical pharmacology 20061101
Title: Simultaneous estimation of six anti-diabetic drugs--glibenclamide, gliclazide, glipizide, pioglitazone, repaglinide and rosiglitazone: development of a novel HPLC method for use in the analysis of pharmaceutical formulations and its application to human plasma assay.
Journal: Biomedical chromatography : BMC 20061001
Title: Use of repaglinide during the first weeks of pregnancy in two type 2 diabetic women.
Journal: Diabetes care 20061001
Title: Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Journal: Diabetologia 20060901
Title: Cyclosporine A increases plasma concentrations and effects of repaglinide.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060901
Title: Pharmacological interaction between cyclosporine a and repaglinide. Is it clinically relevant?
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060901
Title: Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial.
Journal: Diabetes care 20060801
Title: Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20060801
Title: Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.
Journal: Neurology 20060725
Title: A novel calcium silicate based microspheres of repaglinide: in vivo investigations.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20060628
Title: Ionization, lipophilicity and solubility properties of repaglinide.
Journal: Journal of pharmaceutical and biomedical analysis 20060607
Title: Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS.
Journal: Journal of pharmaceutical and biomedical analysis 20060503
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Peroxisome proliferator-activated receptor gamma agonists in renal disease.
Journal: European journal of endocrinology 20060501
Title: Safety profile of repaglinide as used in general practice in England: results of a prescription-event monitoring study.
Journal: Acta diabetologica 20060501
Title: Transporters as a determinant of drug clearance and tissue distribution.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20060401
Title: Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20060401
Title: Meglitinide analogues: a review of clinical data focused on recent trials.
Journal: Diabetes & metabolism 20060401
Title: Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
Journal: European journal of clinical pharmacology 20060301
Title: Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.
Journal: International journal of clinical practice 20060301
Title: Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide.
Journal: Clinical pharmacology and therapeutics 20060301
Title: An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan.
Journal: The Medical journal of Malaysia 20060301
Title: Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20060201
Title: Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20060101
Title: The impact of CYP2C8 polymorphism and grapefruit juice on the pharmacokinetics of repaglinide.
Journal: British journal of clinical pharmacology 20060101
Title: Pioglitazone: a review of its use in type 2 diabetes mellitus.
Journal: Drugs 20060101
Title: Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.
Journal: Current medicinal chemistry 20060101
Title: Effect of repaglinide on endothelial dysfunction during a glucose tolerance test in subjects with impaired glucose tolerance.
Journal: Cardiovascular diabetology 20060101
Title: Treatment of impaired glucose tolerance with acarbose and its effect on intima-media thickness: a substudy of the STOP-NIDDM trial (study to prevent non-insulin-dependent diabetes mellitus).
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101
Title: Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin.
Journal: Diabetes/metabolism research and reviews 20060101
Title: Development and validation of a new high-performance liquid chromatography method for the determination of gliclazide and repaglinide in pharmaceutical formulations.
Journal: Journal of AOAC International 20060101
Title: Spotlight on pioglitazone in type 2 diabetes mellitus.
Journal: Treatments in endocrinology 20060101
Title: Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.
Journal: Health and quality of life outcomes 20060101
Title: Type 2 diabetes mellitus: a review of pharmacological treatment.
Journal: Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria 20060101
Title: Basic Management of Diabetes Mellitus: Practical guidelines.
Journal: The Libyan journal of medicine 20060101
Title: Modification of cardiac oxidative stress in alloxan-induced diabetic rabbits with repaglinide treatment.
Journal: Life sciences 20051205
Title: Oral agents in managing diabetes mellitus in children and adolescents.
Journal: Pediatric clinics of North America 20051201
Title: [Synthesis and insulinotropic activity of 2-benzylidenesuccinic acid derivatives].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20051201
Title: Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20051003
Title: Repaglinide treatment amplifies first-phase insulin secretion and high-frequency pulsatile insulin release in Type 2 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20051001
Title: Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin.
Journal: Basic & clinical pharmacology & toxicology 20051001
Title: Cyclosporine markedly raises the plasma concentrations of repaglinide.
Journal: Clinical pharmacology and therapeutics 20051001
Title: [Recent oral antidiabetic therapy].
Journal: Revue medicale de Bruxelles 20050901
Title: Antioxidative and anti-inflammatory effects of repaglinide in plasma of diabetic animals.
Journal: Pharmacological research 20050801
Title: Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.
Journal: British journal of clinical pharmacology 20050801
Title: Repaglinide/bedtime NPH insulin is comparable to twice-daily NPH insulin.
Journal: Diabetes care 20050701
Title: Mild, reversible pancytopenia induced by rosiglitazone.
Journal: Diabetes care 20050601
Title: Oxidative stress in kidney and liver of alloxan-induced diabetic rabbits: effect of repaglinide.
Journal: Acta diabetologica 20050601
Title: Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Journal: Clinical pharmacology and therapeutics 20050601
Title: Prediction of genotoxicity of chemical compounds by statistical learning methods.
Journal: Chemical research in toxicology 20050601
Title: Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study.
Journal: Diabetes & metabolism 20050601
Title: Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients.
Journal: Diabetes care 20050501
Title: Effects of repaglinide on oxidative stress in tissues of diabetic rabbits.
Journal: Diabetes research and clinical practice 20050501
Title: In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.
Journal: Pharmaceutical research 20050401
Title: Cholestatic hepatitis associated with repaglinide.
Journal: Diabetes care 20050301
Title: [Comparison of efficacy between nateglinide and repaglinide in treating type 2 diabetes: a randomized controlled double-blind clinical trial].
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20050301
Title: Oral antihyperglycemic agents and renal disease: new agents, new concepts.
Journal: Journal of the American Society of Nephrology : JASN 20050301
Title: Repaglinide administration improves brachial reactivity in type 2 diabetic patients.
Journal: Diabetes care 20050201
Title: Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Journal: British journal of pharmacology 20050201
Title: Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus.
Journal: The Israel Medical Association journal : IMAJ 20050201
Title: Sulfonylurea induced beta-cell apoptosis in cultured human islets.
Journal: The Journal of clinical endocrinology and metabolism 20050101
Title: Effect of repaglinide and gliclazide on postprandial control of endogenous glucose production.
Journal: Metabolism: clinical and experimental 20050101
Title: Examination of 209 drugs for inhibition of cytochrome P450 2C8.
Journal: Journal of clinical pharmacology 20050101
Title: Islet adaptation to insulin resistance: mechanisms and implications for intervention.
Journal: Diabetes, obesity & metabolism 20050101
Title: Cardiovascular risk factors associated with insulin resistance: effects of oral antidiabetic agents.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101
Title: Drug interactions of clinical importance with antihyperglycaemic agents: an update.
Journal: Drug safety 20050101
Title: Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.
Journal: Clinical pharmacokinetics 20050101
Title: Postprandial glucose regulation: new data and new implications.
Journal: Clinical therapeutics 20050101
Title: Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes.
Journal: Core evidence 20050101
Title: The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium.
Journal: Diabetes 20041201
Title: Accuracy of continuous nocturnal glucose screening after 48 and 72 hours in type 2 diabetes patients on combined oral and insulin therapy.
Journal: Diabetes & metabolism 20041201
Title: Acute hepatotoxicity caused by repaglinide.
Journal: Annals of internal medicine 20041116
Title: Detection of anti-diabetics in equine plasma and urine by liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20041105
Title: Pre-prandial vs. post-prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet-treated or metformin-treated Type 2 diabetes: a randomized controlled clinical trial.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20041101
Title: Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent.
Journal: Bioorganic & medicinal chemistry letters 20041018
Title: Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinide.
Journal: British journal of clinical pharmacology 20041001
Title: The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial results.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20041001
Title: Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
Journal: Biochemical pharmacology 20040901
Title: Beta-cell insulin secretory response to oral hypoglycemic agents is blunted in humans in vivo during moderate hypoglycemia.
Journal: The Journal of clinical endocrinology and metabolism 20040901
Title: Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Journal: Pharmacological research 20040801
Title: Comparing the long-term cost-effectiveness of repaglinide plus metformin versus nateglinide plus metformin in type 2 diabetes patients with inadequate glycaemic control: an application of the CORE Diabetes Model in type 2 diabetes.
Journal: Current medical research and opinion 20040801
Title: Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar.
Journal: Health news (Waltham, Mass.) 20040801
Title: Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
Journal: Circulation 20040713
Title: Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
Journal: Nuclear medicine and biology 20040701
Title: Enhancement of early- and late-phase insulin secretion and insulin sensitivity by the combination of repaglinide and metformin in type 2 diabetes mellitus.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20040701
Title: Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.
Journal: Diabetes care 20040601
Title: Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Journal: Diabetes, nutrition & metabolism 20040601
Title: Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis.
Journal: European journal of pharmacology 20040510
Title: The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan.
Journal: Endocrine research 20040501
Title: Inhibitors of ATP-sensitive potassium channels in guinea pig isolated ischemic hearts.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20040401
Title: The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
Journal: British journal of clinical pharmacology 20040401
Title: Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide.
Journal: European journal of clinical pharmacology 20040401
Title: Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes.
Journal: Diabetes research and clinical practice 20040401
Title: Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20040401
Title: Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
Journal: Archives of internal medicine 20040308
Title: The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.
Journal: Diabetes, obesity & metabolism 20040301
Title: Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
Journal: Diabetes research and clinical practice 20040201
Title: Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study.
Journal: Diabetes & metabolism 20040201
Title: The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Journal: The Journal of clinical endocrinology and metabolism 20040101
Title: Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.
Journal: Clinical pharmacokinetics 20040101
Title: Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Journal: PharmacoEconomics 20040101
Title: Mitiglinide: KAD 1229, S 21403.
Journal: Drugs in R&D 20040101
Title: Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
Journal: Diabetes/metabolism research and reviews 20040101
Title: Interactions between grapefruit juice and cardiovascular drugs.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101
Title: Continuous glucose monitoring: physiologic and pathophysiologic significance.
Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne 20040101
Title: The efficacy of repaglinide monotherapy and in combination with metformin in Indonesian type 2 diabetes mellitus patients.
Journal: Acta medica Indonesiana 20040101
Title: [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Journal: MMW Fortschritte der Medizin 20031218
Title: Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
Journal: Diabetes care 20031201
Title: Comparison of repaglinide and nateglinide in combination with metformin: response to Raskin et al.
Journal: Diabetes care 20031201
Title: Determination of repaglinide in pharmaceutical formulations by HPLC with UV detection.
Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20031201
Title: Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
Journal: British journal of cancer 20031117
Title: [Type 2 diabetes mellitus pathogenesis: new therapeutic managements?].
Journal: La Revue de medecine interne 20031101
Title: Comparison of repaglinide vs. gliclazide in combination with bedtime NPH insulin in patients with Type 2 diabetes inadequately controlled with oral hypoglycaemic agents.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20031101
Title: Neuronal calcium sensor proteins are direct targets of the insulinotropic agent repaglinide.
Journal: The Biochemical journal 20031001
Title: Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide.
Journal: Clinical pharmacology and therapeutics 20031001
Title: Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20031001
Title: CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Journal: British journal of clinical pharmacology 20030901
Title: Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20030901
Title: Cardiovascular risk in type 2 diabetics and pharmacological regulation of mealtime glucose excursions.
Journal: Diabetes & metabolism 20030901
Title: Impurity profile study of repaglinide.
Journal: Journal of pharmaceutical and biomedical analysis 20030714
Title: Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.
Journal: Diabetes care 20030701
Title: [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
Journal: Drug and therapeutics bulletin 20030701
Title: A comparison of costs for four oral antidiabetic regimens within a managed care population.
Journal: Managed care interface 20030701
Title: Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin.
Journal: Diabetes research and clinical practice 20030601
Title: The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 20030601
Title: Influence of drugs interacting with CYP3A4 on the pharmacokinetics, pharmacodynamics, and safety of the prandial glucose regulator repaglinide.
Journal: Journal of clinical pharmacology 20030601
Title: [Meglitinide analogs: new insulinotropic agents for the treatment of non-insulin dependent diabetes].
Journal: Revue medicale de Bruxelles 20030601
Title: [Differences between oral antidiabetics].
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20030320
Title: Safety and efficacy of repaglinide in type 2 diabetic patients with and without impaired renal function.
Journal: Diabetes care 20030301
Title: Metformin-induced hemolytic anemia in a patient with glucose-6- phosphate dehydrogenase deficiency.
Journal: Diabetes care 20030301
Title: Pharmacologic restoration of the early insulin response in pre-diabetic monkeys controls mealtime glucose excursions without peripheral hyperinsulinaemia.
Journal: Diabetologia 20030301
Title: The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
Journal: Diabetologia 20030301
Title: The mechanisms underlying the unique pharmacodynamics of nateglinide.
Journal: Diabetologia 20030301
Title: Rationale and options for combination therapy in the treatment of Type 2 diabetes.
Journal: Diabetologia 20030301
Title: Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide.
Journal: Diabetologia 20030301
Title: Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.
Journal: Clinical therapeutics 20030201
Title: The effect of repaglinide on insulin secretion and oxidative stress in type 2 diabetic patients.
Journal: Diabetes research and clinical practice 20030101
Title: Pharmacokinetics of repaglinide in healthy caucasian and Japanese subjects.
Journal: Journal of clinical pharmacology 20030101
Title: Differential selectivity of insulin secretagogues: mechanisms, clinical implications, and drug interactions.
Journal: Journal of diabetes and its complications 20030101
Title: Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
Journal: PharmacoEconomics 20030101
Title: [Drug safety. Notes regarding drug surveillance].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20030101
Title: Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus.
Journal: Treatments in endocrinology 20030101
Title: Effects of S 21403 on hormone secretion from isolated rat pancreas at different glucose concentrations.
Journal: European journal of pharmacology 20021205
Title: No effect of the novel antidiabetic agent nateglinide on the pharmacokinetics and anticoagulant properties of warfarin in healthy volunteers.
Journal: Journal of clinical pharmacology 20021201
Title: Sulfonylurea stimulation of insulin secretion.
Journal: Diabetes 20021201
Title: Early changes in beta-cell function and insulin pulsatility as predictors for type 2 diabetes.
Journal: Diabetes, nutrition & metabolism 20021201
Title: Repaglinide at a cellular level.
Journal: Diabetes, nutrition & metabolism 20021201
Title: Early-phase prandial insulin secretion: its role in the pathogenesis of type 2 diabetes mellitus and its modulation by repaglinide.
Journal: Diabetes, nutrition & metabolism 20021201
Title: The impact of prandial glucose regulation in practice.
Journal: Diabetes, nutrition & metabolism 20021201
Title: Repaglinide in combination therapy.
Journal: Diabetes, nutrition & metabolism 20021201
Title: High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology.
Journal: Diabetes & metabolism 20021201
Title: Hypoglycemia probably due to accidental intake of repaglinide.
Journal: Chang Gung medical journal 20021101
Title: Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting.
Journal: Diabetes research and clinical practice 20021001
Title: Repaglinide versus metformin in combination with bedtime NPH insulin in patients with type 2 diabetes established on insulin/metformin combination therapy.
Journal: Diabetes care 20021001
Title: Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.
Journal: Diabetes 20020901
Title: [Structures and mechanisms for non SU insulin secretagogues].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: [Repaglinide (NN-623)].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20020901
Title: A novel simple method for the investigation of drug binding to the K(ATP) channel sulfonylurea receptor.
Journal: Analytical biochemistry 20020815
Title: Comparison of the effects of three insulinotropic drugs on plasma insulin levels after a standard meal.
Journal: Diabetes care 20020801
Title: Response to Schmitz. Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide.
Journal: Diabetes care 20020801
Title: [Differential type 2 diabetes therapy based on pathophysiological aspects].
Journal: Therapeutische Umschau. Revue therapeutique 20020801
Title: Nateglinide, but not repaglinide, stimulates growth hormone release in rat pituitary cells by inhibition of K channels and stimulation of cyclic AMP-dependent exocytosis.
Journal: European journal of endocrinology 20020701
Title: Interaction of nateglinide with K(ATP) channel in beta-cells underlies its unique insulinotropic action.
Journal: European journal of pharmacology 20020503
Title: [Glinides and glitazones in diabetes treatment. Are they really effective?].
Journal: MMW Fortschritte der Medizin 20020502
Title: Current oral agents for type 2 diabetes. Many options, but which to choose when?
Journal: Postgraduate medicine 20020501
Title: Insulinotropic meglitinide analogues.
Journal: Lancet (London, England) 20020406
Title: Subclinical type 1 diabetes.
Journal: Journal of the Royal Society of Medicine 20020401
Title: [Postprandial hyperglycemia. II. Pharmacological approaches].
Journal: Revue medicale de Liege 20020401
Title: Control of post-prandial hyperglycemia--an essential part of good diabetes treatment and prevention of cardiovascular complications.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD 20020401
Title: Optimizing insulin secretagogue therapy in patients with type 2 diabetes: a randomized double-blind study with repaglinide.
Journal: Diabetes care 20020201
Title: Oral antihyperglycemic therapy for type 2 diabetes: scientific review.
Journal: JAMA 20020116
Title: Type 2 diabetes management.
Journal: British journal of community nursing 20020101
Title: Modeling the pharmacokinetics and pharmacodynamics of a unique oral hypoglycemic agent using neural networks.
Journal: Pharmaceutical research 20020101
Title: The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.
Journal: Journal of diabetes and its complications 20020101
Title: Type 2 diabetes management: a comprehensive clinical review of oral medications.
Journal: Comprehensive therapy 20020101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20020101
Title: Clinical pharmacokinetics and pharmacodynamics of repaglinide.
Journal: Clinical pharmacokinetics 20020101
Title: Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
Journal: Arzneimittel-Forschung 20020101
Title: Insulin secretagogues.
Journal: Current medical research and opinion 20020101
Title: Preventing the progressive nature of type 2 diabetes.
Journal: Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20020101
Title: Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection.
Journal: Clinical pharmacokinetics 20020101
Title: Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
Journal: Journal of postgraduate medicine 20020101
Title: Postprandial hyperglycemia in patients with type 2 diabetes mellitus.
Journal: Treatments in endocrinology 20020101
Title: Insulinotropic meglitinide analogues.
Journal: Lancet (London, England) 20011117
Title: The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Journal: European journal of pharmacology 20011109
Title: Nateglinide therapy for type 2 diabetes mellitus.
Journal: The Annals of pharmacotherapy 20011101
Title: [Therapy of type 2 diabetes. Avoiding postprandial blood glucose peaks!].
Journal: MMW Fortschritte der Medizin 20011004
Title: Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.
Journal: Diabetes care 20011001
Title: Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes.
Journal: Diabetes care 20011001
Title: Effect of insulinotropic agent nateglinide on Kv and Ca(2+) channels in pancreatic beta-cell.
Journal: European journal of pharmacology 20010914
Title: Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.
Journal: Current pharmaceutical design 20010901
Title: Repaglinide improves blood glucose control in sulphonylurea-naive type 2 diabetes.
Journal: Diabetes research and clinical practice 20010901
Title: [New drugs].
Journal: Revue medicale de Bruxelles 20010901
Title: [News in oral antidiabetic therapy].
Journal: Vnitrni lekarstvi 20010901
Title: [Repaglinide, potentially a therapeutic improvement for diabetes mellitus type 2].
Journal: Nederlands tijdschrift voor geneeskunde 20010811
Title: Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
Journal: Diabetes care 20010801
Title: A new era in type 2 diabetes mellitus treatment?
Journal: The American journal of medicine 20010701
Title: The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide.
Journal: Clinical pharmacology and therapeutics 20010701
Title: [Objectives and therapeutic strategy in type 2 diabetes mellitus].
Journal: Anales de medicina interna (Madrid, Spain : 1984) 20010701
Title: Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Journal: Diabetologia 20010601
Title: [Pharma-clinics. Medication of the month. Repaglinide (NovoNorm)].
Journal: Revue medicale de Liege 20010601
Title: [Repaglinide].
Journal: Deutsche medizinische Wochenschrift (1946) 20010511
Title: Single- and multiple-dose pharmacokinetics of repaglinide in patients with type 2 diabetes and renal impairment.
Journal: European journal of clinical pharmacology 20010501
Title: Comparison between repaglinide and glipizide in Type 2 diabetes mellitus: a 1-year multicentre study.
Journal: Diabetic medicine : a journal of the British Diabetic Association 20010501
Title: Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.
Journal: Diabetes, obesity & metabolism 20010401
Title: [Large general practice study with repaglinide. Fewer 'anxiety eating' in diabetic patients].
Journal: MMW Fortschritte der Medizin 20010308
Title: Repaglinide-induced factitious hypoglycemia.
Journal: The Journal of clinical endocrinology and metabolism 20010201
Title: Repaglinide and diabetes: new preparation. No better than glucose-lowering sulphonamides.
Journal: Prescrire international 20010201
Title: Current understanding regarding the role of repaglinide in post-prandial hyperglycemia.
Journal: The Journal of the Association of Physicians of India 20010125
Title: The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
Journal: The Journal of the Association of Physicians of India 20010125
Title: Combination therapy in type 2 diabetes: the role of repaglinide.
Journal: The Journal of the Association of Physicians of India 20010125
Title: Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes.
Journal: Diabetes care 20010101
Title: Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
Journal: Diabetes care 20010101
Title: Honing type 2 diabetes treatment.
Journal: Health news (Waltham, Mass.) 20010101
Title: Oral hypoglycemic agents: insulin secretagogues, alpha-glucosidase inhibitors and insulin sensitizers.
Journal: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20010101
Title: Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.
Journal: Drugs 20010101
Title: [New molecules].
Journal: Journal de pharmacie de Belgique 20010101
Title: Patient perceptions of prandial oral therapy for type 2 diabetes.
Journal: The Diabetes educator 20010101
Title: Glucose-dependent and glucose-sensitizing insulinotropic effect of nateglinide: comparison to sulfonylureas and repaglinide.
Journal: International journal of experimental diabetes research 20010101
Title: Effectiveness of nateglinide on in vitro insulin secretion from rat pancreatic islets desensitized to sulfonylureas.
Journal: International journal of experimental diabetes research 20010101
Title: Pharmacology and clinical experience with repaglinide.
Journal: Expert opinion on investigational drugs 20000401
Title: Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore). 2018 Sep;97(38):e12476.
